Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) in chronic hypoxia- and antigen-mediated pulmonary vascular remodeling
暂无分享,去创建一个
Chris Cheadle | Chunling Fan | C. Cheadle | R. Johns | Qingning Su | Qingning Su | Daniel J. Angelini | Roger A Johns | Daniel J Angelini | Kazuyo Yamaji-Kegan | John T Skinner | Andre Poloczek | Hazim El-Haddad | J. Skinner | Kazuyo Yamaji-Kegan | H. El-Haddad | A. Poloczek | Chunling Fan
[1] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[2] Yan Sun,et al. Found in Inflammatory Zone 1 Induces Angiogenesis in Murine Models of Asthma , 2008, Lung.
[3] S. Dhanasekaran,et al. FIZZ1 stimulation of myofibroblast differentiation. , 2004, The American journal of pathology.
[4] N. Morrell,et al. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. , 2002, Progress in cardiovascular diseases.
[5] G. Butrous,et al. Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis. , 2010, American journal of respiratory and critical care medicine.
[6] Jinshui Fan,et al. Erythroid-Specific Transcriptional Changes in PBMCs from Pulmonary Hypertension Patients , 2011, PloS one.
[7] Liduan Zheng,et al. Hypoxia-Induced Mitogenic Factor Promotes Vascular Adhesion Molecule-1 Expression via the PI-3K/Akt–NF-κB Signaling Pathway , 2006 .
[8] R. Johns. Th2 inflammation, hypoxia-induced mitogenic factor/FIZZ1, and pulmonary hypertension and vascular remodeling in schistosomiasis. , 2010, American journal of respiratory and critical care medicine.
[9] L. Piccio,et al. Cutting Edge: TREM-2 Attenuates Macrophage Activation1 , 2006, The Journal of Immunology.
[10] S. Phan,et al. Antiapoptotic effect of found in inflammatory zone (FIZZ)1 on mouse lung fibroblasts , 2007, The Journal of pathology.
[11] C. Cheadle,et al. Hypoxia-Induced Mitogenic Factor (HIMF/FIZZ1/RELMα) Increases Lung Inflammation and Activates Pulmonary Microvascular Endothelial Cells via an IL-4–Dependent Mechanism , 2010, The Journal of Immunology.
[12] I. Purvis,et al. Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis. , 2011, American journal of respiratory and critical care medicine.
[13] M. Humbert,et al. The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension , 2013, Clinical Reviews in Allergy & Immunology.
[14] T. L. Le Cras,et al. Chronic Allergic Inflammation Causes Vascular Remodeling and Pulmonary Hypertension in Bmpr2 Hypomorph and Wild-Type Mice , 2012, PloS one.
[15] Liduan Zheng,et al. Hypoxia-induced mitogenic factor modulates surfactant protein B and C expression in mouse lung. , 2006, American journal of respiratory cell and molecular biology.
[16] R. Johns,et al. Bruton's tyrosine kinase (BTK) is a binding partner for hypoxia induced mitogenic factor (HIMF/FIZZ1) and mediates myeloid cell chemotaxis , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] J. Erjefält,et al. Allergen exposure of mouse airways evokes remodeling of both bronchi and large pulmonary vessels. , 2005, American journal of respiratory and critical care medicine.
[18] Chris Cheadle,et al. Application of z-score transformation to Affymetrix data. , 2003, Applied bioinformatics.
[19] M. Rothenberg,et al. Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis. , 2008, The Journal of allergy and clinical immunology.
[20] R. Johns,et al. Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension. , 2009, American journal of respiratory cell and molecular biology.
[21] R. Johns,et al. Hypoxia-induced mitogenic factor has antiapoptotic action and is upregulated in the developing lung: coexpression with hypoxia-inducible factor-2alpha. , 2004, American journal of respiratory cell and molecular biology.
[22] Chuanshu Huang,et al. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-κB signaling pathway , 2006, Respiratory research.
[23] N. Lee,et al. Diagnosis and assessment of pulmonary arterial hypertension , 2010 .
[24] Chuanshu Huang,et al. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells. , 2006, Experimental cell research.
[25] C. Munaut,et al. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension , 2005, European Respiratory Journal.
[26] C. Ricachinevsky,et al. Treatment of pulmonary arterial hypertension. , 2006, Jornal de pediatria.
[27] B. Camoretti-Mercado,et al. FIZZ1 Plays a Crucial Role in Early Stage Airway Remodeling of OVA-Induced Asthma , 2008, The Journal of asthma : official journal of the Association for the Care of Asthma.
[28] A. Anwar,et al. Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[29] R. Johns,et al. Hypoxia-Induced Mitogenic Factor (HIMF/FIZZ1/RELMα) Recruits Bone Marrow-Derived Cells to the Murine Pulmonary Vasculature , 2010, PloS one.
[30] V. Kurup,et al. Pulmonary arterial remodeling induced by a Th2 immune response , 2008, The Journal of experimental medicine.
[31] M. Rabinovitch,et al. Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. , 1996, Circulation research.
[32] T. Welte,et al. Pivotal role of cathepsin K in lung fibrosis. , 2004, The American journal of pathology.
[33] R. Mecham,et al. Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. , 1987, Science.
[34] R. Mecham,et al. Vascular remodeling in neonatal pulmonary hypertension. Role of the smooth muscle cell. , 1988, Chest.
[35] M. Frid,et al. Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[36] A. Stütz,et al. The Th2 Cell Cytokines IL-4 and IL-13 Regulate Found in Inflammatory Zone 1/Resistin-Like Molecule α Gene Expression by a STAT6 and CCAAT/Enhancer-Binding Protein-Dependent Mechanism , 2003, The Journal of Immunology.
[37] T. Wibmer,et al. Circulating biomarkers of tissue remodelling in pulmonary hypertension , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[38] R. Johns,et al. FIZZ1/RELM&agr;, a Novel Hypoxia-Induced Mitogenic Factor in Lung With Vasoconstrictive and Angiogenic Properties , 2003, Circulation research.
[39] R. Speich,et al. Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[40] R. Johns,et al. Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMalpha) induces the vascular and hemodynamic changes of pulmonary hypertension. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[41] G. Butrous,et al. Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling. , 2010, The American journal of pathology.
[42] S. Swain,et al. Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia. , 2007, The American journal of pathology.
[43] R. Johns,et al. Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[44] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] P. Jones,et al. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. , 1997, The American journal of pathology.
[46] Joseph Loscalzo,et al. Pathogenic mechanisms of pulmonary arterial hypertension. , 2008, Journal of molecular and cellular cardiology.
[47] R. Johns,et al. Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat. , 1996, Hypertension.
[48] R. Baier,et al. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia , 2004, Pediatric pulmonology.
[49] M. Humbert,et al. Inflammation in pulmonary arterial hypertension , 2003, European Respiratory Journal.
[50] R. Johns,et al. Regression of chronic hypoxic pulmonary hypertension by simvastatin. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[51] Chris Cheadle,et al. GSMA: Gene Set Matrix Analysis, An Automated Method for Rapid Hypothesis Testing of Gene Expression Data , 2007, Bioinformatics and biology insights.
[52] J. Erjefält,et al. Remodeling of extra-bronchial lung vasculature following allergic airway inflammation , 2008, Respiratory research.
[53] Seon-Young Kim,et al. PAGE: Parametric Analysis of Gene Set Enrichment , 2005, BMC Bioinform..
[54] W. Seeger,et al. Human RELMβ is a mitogenic factor in lung cells and induced in hypoxia , 2006, FEBS letters.
[55] F. Peale,et al. FIZZ1, a novel cysteine‐rich secreted protein associated with pulmonary inflammation, defines a new gene family , 2000, The EMBO journal.
[56] R. Johns,et al. eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[57] Biao Hu,et al. Regulation of Found in Inflammatory Zone 1 Expression in Bleomycin-Induced Lung Fibrosis: Role of IL-4/IL-13 and Mediation via STAT-61 , 2004, The Journal of Immunology.
[58] R. Johns,et al. IL-4 Is Proangiogenic in the Lung under Hypoxic Conditions1 , 2009, The Journal of Immunology.
[59] H. Boushey,et al. The Epithelial Anion Transporter Pendrin Is Induced by Allergy and Rhinovirus Infection, Regulates Airway Surface Liquid, and Increases Airway Reactivity and Inflammation in an Asthma Model1 , 2008, The Journal of Immunology.
[60] Chuanshu Huang,et al. Participation of the PI-3K/Akt-NF-κB signaling pathways in hypoxia-induced mitogenic factor-stimulated Flk-1 expression in endothelial cells , 2006, Respiratory research.
[61] D. Lison,et al. Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-β , 2005, Respiratory research.
[62] R. Tuder,et al. Pathology of pulmonary hypertension. , 2007, Clinics in chest medicine.
[63] C. Cheadle,et al. Resistin-like molecule α stimulates proliferation of mesenchymal stem cells while maintaining their multipotency. , 2013, Stem cells and development.
[64] V. Laubach,et al. Upregulation of hypoxia-induced mitogenic factor in compensatory lung growth after pneumonectomy. , 2005, American journal of respiratory cell and molecular biology.
[65] G. Butrous,et al. Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. , 2010, Chest.
[66] Robin Shandas,et al. Changes in the structure-function relationship of elastin and its impact on the proximal pulmonary arterial mechanics of hypertensive calves. , 2008, American journal of physiology. Heart and circulatory physiology.
[67] E. Green,et al. Identification of Pendrin as a Common Mediator for Mucus Production in Bronchial Asthma and Chronic Obstructive Pulmonary Disease1 , 2008, The Journal of Immunology.
[68] M. Rojas,et al. Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. , 2006, American journal of respiratory cell and molecular biology.
[69] M. d’Ortho,et al. Inhibition of Matrix Metalloproteinases by Lung TIMP-1 Gene Transfer or Doxycycline Aggravates Pulmonary Hypertension in Rats , 2000, Circulation research.
[70] D. McKean,et al. Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[71] R. Johns,et al. Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. , 2003, American journal of physiology. Heart and circulatory physiology.